RT Journal Article
SR Electronic
T1 Lower infant mortality and access to contraception reduce fertility in low- and middle-income nations
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.12.16.21267946
DO 10.1101/2021.12.16.21267946
A1 Corey J A Bradshaw
A1 Claire Perry
A1 Chitra Maharani Saraswati
A1 Melinda Judge
A1 Jane Heyworth
A1 Peter N Le Souëf
YR 2021
UL http://medrxiv.org/content/early/2021/12/17/2021.12.16.21267946.abstract
AB Although average contraceptive use has increased globally in recent decades, an estimated 222 million (26%) of women of child-bearing age worldwide face an unmet need for family planning — defined as a discrepancy between fertility preferences and contraception practice, or failing to translate desires to avoid pregnancy into preventative behaviours and practices.While many studies have reported relationships between availability of contraception, infant mortality, and fertility, these relationships have not been evaluated quantitatively across a broad range of low- and middle-income countries. Using publicly available data from 46 low- and middle-income countries, we collated test and control variables in six themes: (i) availability of family planning, (ii) quality of family planning, (iii) maternal education, (iv) religion, (v) mortality, and (vi) socio-economic conditions. We predicted that higher nation-level availability/quality of family-planning services, maternal education, and wealth reduce average fertility, whereas higher infant mortality and religious adherence increase it. Given the sample size, we first constructed general linear models to test for relationships between fertility and the variables from each theme, from which we retained those with the highest explanatory power within a final general linear model set to determine the partial correlation of dominant test variables. We also applied boosted regression trees, generalised least-squares models, and a generalised linear mixed-effects models to account for non-linearity and spatial autocorrelation. On average among all countries, we found an association between all main variables and fertility, with reduced infant mortality having the strongest relationship with reduced fertility. Access to contraception was the next-highest correlate with reduced fertility, with female secondary education, home health visitations, and adherence to Catholicism having weak, if any, explanatory power. Our models suggest that decreasing infant mortality and increasing access to contraception will have the greatest effect on decreasing global fertility. We thus provide new evidence that progressing the United Nation’s Sustainable Development Goals for reducing infant mortality can be accelerated by increasing access to any form of family planning.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe University of Western AustraliaAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:- Demographic and Health Surveys (dhsprogram.com) - Family Planning Effort Index (track20.org/pages/data_analysis/policy/FPE.php) - Multiple Indicator Cluster Surveys (mics.unicef.org) - National Composite Index on Family Planning (track20.org/pages/data_analysis/policy/NCIFP.php) - World Bank (data.worldbank.org) - World Factbook (cia.gov/the-world-factbook) - World Health Organization Global Health Observatory data repositories (who.int/data/gho)I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data and R code to repeat the analyses are provided at github.com/cjabradshaw/humanfertility http://github.com/cjabradshaw/humanfertility